Patent · US Active

Inhibitors of hemeprotein-catalyzed lipid peroxidation

US9545385B2 · kind B2 · utility

0Cited by
1References
16Claims
0Family size

Assignee

Inventors

Key dates

Filing dateFeb 5, 2014
Grant dateJan 17, 2017
Priority date
Expiry dateFeb 5, 2034

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D498/04
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Compounds, compositions and methods related to the prevention or treatment of isoprostane-mediated tissue damage in a mammalian subject in need thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.